Bailing Hsu. PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease[J]. The Journal of Biomedical Research, 2013, 27(6): 452-459. DOI: 10.7555/JBR.27.20130136
Citation:
Bailing Hsu. PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease[J]. The Journal of Biomedical Research, 2013, 27(6): 452-459. DOI: 10.7555/JBR.27.20130136
Bailing Hsu. PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease[J]. The Journal of Biomedical Research, 2013, 27(6): 452-459. DOI: 10.7555/JBR.27.20130136
Citation:
Bailing Hsu. PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease[J]. The Journal of Biomedical Research, 2013, 27(6): 452-459. DOI: 10.7555/JBR.27.20130136
Assessment of the relative distribution of myocardial flow with myocardial perfusion imaging (MPI) is meth?odologically limited to predict the presence or absence of flow-limited coronary artery disease (CAD). This limi?tation may often occur, when obstructive lesions involve multiple epicardial coronary arteries or disease-related disturbances of the coronary circulation coexist at the microvascular level. Non-invasive assessment of myocar?dial blood flow in absolute units with position emission tomography (PET) has been positioned as the solution to improve CAD diagnosis and prediction of patient outcomes associated with risks for cardiac events. This article reviews technical and clinical aspects of myocardial blood flow quantitation with PET and discusses the practical consideration of this approach toward worldwide clinical utilization.
Guan M, Wang Y. Common variants of vitamin D receptor gene polymorphisms and risk of gastric cancer: A meta-analysis. Medicine (Baltimore), 2024, 103(35): e39527.
DOI:10.1097/MD.0000000000039527
2.
Abo-Amer YE, Mohamed AA, Elhoseeny MM, et al. Association Between Vitamin D Receptor Polymorphism and the Response to Helicobacter Pylori Treatment. Infect Drug Resist, 2023, 16: 4463-4469.
DOI:10.2147/IDR.S414186
3.
Liu X, Zhou Y, Zou X. Correlation between Serum 25-Hydroxyvitamin D Levels and Gastric Cancer: A Systematic Review and Meta-Analysis. Curr Oncol, 2022, 29(11): 8390-8400.
DOI:10.3390/curroncol29110661
4.
Nguyen MT, Huynh NNY, Nguyen DD, et al. Vitamin D intake and gastric cancer in Viet Nam: a case-control study. BMC Cancer, 2022, 22(1): 838.
DOI:10.1186/s12885-022-09933-2
5.
Kwak JH, Paik JK. Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans. Nutrients, 2020, 12(7): 2004.
DOI:10.3390/nu12072004
6.
Durak Ş, Gheybi A, Demirkol Ş, et al. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer. Mol Biol Rep, 2019, 46(6): 6413-6420.
DOI:10.1007/s11033-019-05088-9
7.
Kazemian E, Akbari ME, Moradi N, et al. Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial. Nutrients, 2019, 11(6): 1264.
DOI:10.3390/nu11061264
8.
Cai H, Jing C, Chang X, et al. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J Transl Med, 2019, 17(1): 189.
DOI:10.1186/s12967-019-1941-0